Crossref
Migraine Disorders: Pathophysiology and Emerging Liposomal Drug Delivery Approaches
Indian Journal of Pharmaceutical Education and Research · 23.10.2026 · 61 (1) · 33-42
DOI: 10.5530/ijper.20273308 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Pharmaceutical Education and Research, online erschienen am 23.10.2026. Verfasst von Sanjana Katlaria und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Katlaria, S., & Tyagi, Y. (2026). Migraine Disorders: Pathophysiology and Emerging Liposomal Drug Delivery Approaches. Indian Journal of Pharmaceutical Education and Research, 61(1), 33-42. https://doi.org/10.5530/ijper.20273308
Vancouver
Katlaria S, Tyagi Y. Migraine Disorders: Pathophysiology and Emerging Liposomal Drug Delivery Approaches. Indian Journal of Pharmaceutical Education and Research. 2026;61(1):33-42. doi:10.5530/ijper.20273308
BibTeX
@article{Katlaria2026,
author = {Katlaria, Sanjana and Tyagi, Yogita},
title = {Migraine Disorders: Pathophysiology and Emerging Liposomal Drug Delivery Approaches},
journal = {Indian Journal of Pharmaceutical Education and Research},
year = {2026},
volume = {61},
number = {1},
pages = {33--42},
doi = {10.5530/ijper.20273308}
}
EUVIMED